News

As part of the Commonwealth Government’s response to COVID-19, the National Medical Stockpile (NMS) will secure supply of a number of experimental medicines for use in clinical trials, when those medicines cannot be obtained through usual supply chains.

We’ve created this area for COVID-19 information relevant to clinical trials. In line with the national guidance and emphasis on the safety and well-being of patients, research participants and their families, and health care professionals, researchers and other staff involved in patient care and research, ACTA strongly supports the continuation of investigator-led trials, where it is safe to do so, and with due consideration to any protocol amendments appropriate for the current COVID-19 pandemic.  

The nomination period has been extended to COB Wednesday 20 May, the date the ceremony was originally scheduled.